Did you miss us live in July? Our webinar is available on demand.

Our team of experts answered commonly asked questions about CDMO choice, supply chain constraints, and discussed unique opportunities for entities like Nucleus RadioPharma to bolster the radiotherapies arena.

July 2024 Webinar

“What does Novartis’s pursuit of a label expansion for Pluvicto possibly mean for patients and the field of radiopharmaceutical therapy?”

Did you miss us live in July? Our webinar is available on demand.

Gain insightful knowledge and additional education around hot topics in radiopharmaceutical therapy